Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study

Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study

AimThe aim of the present study was to assess differences in the serum levels of chemokines and growth factors (GFs) between COVID-19 patients and healthy controls. The diagnostic utility of the analyzed proteins for monitoring the severity of the SARS-CoV- 2 infection based on the patients’ MEWS sc...

Full description

Bibliographic Details
Main Authors: Blanka Wolszczak-Biedrzycka, Justyna Dorf, Marzena Wojewódzka-Żelezniakowicz, Małgorzata Żendzian-Piotrowska, Violetta Dymicka-Piekarska, Joanna Matowicka-Karna, Mateusz Maciejczyk
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
chemokines
growth factors
COVID-19
MEWS score
SARS-CoV-2
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1320362/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1320362/full

Similar Items